The Role of Inflammation in Neurodegenerative Diseases: Parkinson’s Disease, Alzheimer’s Disease, and Multiple Sclerosis
Top Cited Papers
Open Access
- 28 May 2025
- journal article
- review article
- Published by MDPI AG in International Journal of Molecular Sciences
- Vol. 26 (11) , 5177
Abstract
Neurodegenerative diseases are a group of conditions that have in common the progressive damage and degeneration of neurons in the central nervous system. This group includes Parkinson’s disease, Alzheimer’s disease, and multiple sclerosis, among others. In recent years, increasing evidence has pointed to the important role of inflammation in the pathogenesis of these conditions. The occurrence of inflammation in the brain, which is often triggered by pro-inflammatory activation of microglia or astrocytes, can consequently lead to a chronic inflammatory response that contributes to the development of neurodegenerative processes. Inflammatory processes themselves, both within the nervous system and throughout the human body, appear to be central to the initiation and progression of neuronal damage. Understanding the role of inflammation in these diseases may open up new perspectives and opportunities in the future in the development of effective therapies to improve patients’ quality of life as the vast majority of cases of patients affected by neurodegenerative diseases continue to be treated symptomatically since causal treatments are lacking. In this review, we provide information on the impact of inflammation on the pathogenesis, course, and potential therapeutic options for selected neurodegenerative diseases. In addition, this article provides a general description of neuroinflammation and the involvement and role of specific cells in the central nervous system.Keywords
Funding Information
- Medical University of Silesia (BNW-2-037/N/4/F, BNW-1-037/N/4/F)
This publication has 134 references indexed in Scilit:
- Uptake of alpha‐synuclein preformed fibrils is suppressed by inflammation and induces an aberrant phenotype in human microgliaGlia, 2024
- MS treatment de-escalation: review and commentaryJournal of Neurology, 2024
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- DNA damage‐induced neuroinflammation in neurodegenerative diseaseAlzheimer's & Dementia, 2021
- Microglia and monocytes in inflammatory CNS disease: integrating phenotype and functionActa Neuropathologica, 2021
- The role of microglia in neuropsychiatric disorders and suicideEuropean Archives of Psychiatry and Clinical Neuroscience, 2021
- How microglia sense and regulate neuronal activityGlia, 2020
- DNA damage induced neuroinflammation in neurodegenerative diseaseAlzheimer's & Dementia, 2020
- Increased Immune Activation by Pathologic α‐Synuclein in Parkinson's DiseaseAnnals of Neurology, 2019
- Pharmacological Treatment of Parkinson DiseaseJAMA, 2014